Conference · San Francisco, California
Pathway-Targeted Therapies in Cancer
Health · Medicine · Wellness
Key numbers
- Editions on record
- 5first in 2012
About Pathway-Targeted Therapies in Cancer
The recent successes of targeted therapies highlight both the opportunities and the challenges of personalizing cancer care. The combination of diagnostic tools with targeted agents can provide dramatic patient benefits, but improving the durability of clinical responses requires juxtaposition of clinical and pre-clinical studies to address the underlying disease biology. The opportunity provided by this paradigm is exemplified by our ongoing studies with RG7204, an inhibitor of V600E-BRAF.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2017 | 19–24 Feb 2017 | Moscone Convention Center San Francisco, California | — | — |
| 2015 | 23–25 Feb 2015 | Moscone Convention Center San Francisco, California | — | — |
| 2014 | 9–14 Feb 2014 | Moscone Convention Center San Francisco, California | — | — |
| 2013 | 23–25 Feb 2013 | Moscone Convention Center San Francisco, California | — | — |
| 2012 | 19–23 Feb 2012 | Moscone Convention Center San Francisco, California | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Pathway-Targeted Therapies in Cancer?
The next edition is expected around February 2027, based on its annual cycle. The organiser hasn't announced the dates yet.
Where is it held?
The last edition we have was at Moscone Convention Center, San Francisco, California.
How often does it take place?
Annual, judging by the 5 editions on record since 2012.